Ticker
RIGLCompany Name
RIGEL PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Total Assets | Goodwill and Intangibles | Goodwill & Intangibles to Assets Ratio |
---|---|---|---|
6/30/2025 | $ 206.74M | $ 25.92M | 12.54% |
3/31/2025 | $ 175.97M | $ 26.51M | 15.07% |
12/31/2024 | $ 163.98M | $ 27.1M | 16.53% |
9/30/2024 | $ 139.42M | $ 27.69M | 19.86% |
6/30/2024 | $ 128.41M | $ 28.27M | 22.02% |
3/31/2024 | $ 126.52M | $ 28.86M | 22.81% |
12/31/2023 | $ 117.22M | $ 13.88M | 11.84% |
9/30/2023 | $ 115.32M | $ 14.15M | 12.27% |
6/30/2023 | $ 117.09M | $ 14.41M | 12.31% |
3/31/2023 | $ 123.61M | $ 14.68M | 11.88% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Intangibles / Assets
(=) Intang. to Assets
Intang. to Assets for RIGEL PHARMACEUTICALS INC is calculated as follows: Intangibles [ $ 0 ] / Assets [ $ 123.06M ]
(=) Intang. to Assets [ 0% ]
Minimum
Sep 30, 2020
Maximum
Mar 31, 2024
Average
Median
filtered constituents | 3.24K |
---|---|
min | 0% |
max | 23.16% |
average | 3.98% |
median | 0.52% |
std | 6.09% |